The authors found concurrent growth in pharmacy benefit manager market concentration and worsening of patient access measures across states from 2016 to 2025.
|Articles|November 1, 1999
Supplements and Featured Publications
- The Clinical and Economic Impact of Pneumococcal Disease in the Pediatric Population
- Volume 5
- Issue 17 Suppl
The Clinical Impact of Pneumococcal Conjugate Vaccines
Author(s)Steven Black, MD
Advertisement
Articles in this issue
about 27 years ago
Participating Facultyabout 27 years ago
Introductionabout 27 years ago
Epidemiology of Pneumococcal Diseaseabout 27 years ago
The Costs of Antimicrobial Treatment Failure in Acute Otitis Mediaabout 27 years ago
Prevention of Pneumococcal Disease in High-Risk Pediatric Groupsabout 27 years ago
Economic Impact of Pneumococcal Conjugate Vaccine in Managed Careabout 27 years ago
Into the Era of the Pneumococcal Conjugate Vaccineabout 27 years ago
Selected Abstractsabout 27 years ago
CME Quizabout 27 years ago
BibliographyAdvertisement
Related to this article
Advertisement
Advertisement
Trending on AJMC
1
Real-World Cohort Ties JAK Inhibitors in Alopecia Areata to Menstrual Side Effects
2
Phase 3 Trial Tests Ensifentrine for COPD Exacerbation Prevention
3
Tarlatamab Plus Durvalumab Cuts Risk of Death by 58% as First-Line Maintenance in ES-SCLC
4
Trends in Pharmacy Benefit Manager Market Dynamics, 2016-2025
5